Related Experiment Video
Updated: May 19, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Pacing in sinus node disease to prevent atrial fibrillation
Mads Brix Kronborg1, Jens Cosedis Nielsen
1Department of Cardiology, Aarhus University Hospital, Skejby, Denmark.
Insights
Cardiac pacing treats sinus node disease (SND) but can increase atrial fibrillation (AF) risk. Preserving optimal atrioventricular coupling during pacing is key to preventing AF in high-risk SND patients.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- Symptomatic sinus node disease (SND) requires cardiac pacing.
- Patients with SND often have risk factors for atrial fibrillation (AF), placing them at high risk.
- Pacemaker therapy can influence atrial and ventricular conduction, potentially affecting AF initiation and maintenance.
Purpose of the Study:
- To review the impact of cardiac pacing on AF in SND patients.
- To explore strategies for reducing AF incidence in this population.
- To highlight the importance of preserving atrioventricular coupling.
Main Methods:
- Review of existing literature on pacemaker modalities and AF in SND.
- Analysis of mechanisms by which pacing affects cardiac electrophysiology.
- Evaluation of different pacemaker algorithms designed to mitigate AF.
Main Results:
- Pacemaker pacing in SND can alter conduction and atrioventricular coupling.
- These alterations can either prevent or promote AF.
- Various pacing strategies and algorithms have been investigated to reduce AF occurrence.
Conclusions:
- Optimizing electromechanical function, particularly atrioventricular coupling, is crucial.
- Mimicking the heart's natural function may help prevent AF in SND patients.
- Careful pacemaker selection and programming are essential for managing AF risk.
Abstract:
Cardiac pacing is the only effective treatment for patients with symptomatic sinus node disease (SND). The majority of patients with SND have several risk factors associated with development of atrial fibrillation (AF) at the time of pacemaker implantation and are therefore considered a high-risk population. Patients with SND can be treated with any kind of commercially available pacemaker pacing in the atrium, the ventricle or both. Pacing in SND can therefore alter atrial and ventricular conduction and atrioventricular coupling. These mechanisms can prevent or contribute to initiation and maintenance of AF during pacing. Different pacemaker modalities and algorithms have been tested to reduce AF in patients with SND in recent decades. To prevent AF in this population, it seems to be important to mimic the optimal electromechanical function of the heart, especially to preserve an optimal atrioventricular coupling.
Related Concept Videos
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism, and...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias

